Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GSK2256294A (GSK 2256294) is potent, selective inhibitor of recombinant human, rat and mouse sEH with IC50 of 27 pM, 61 pM and 189 pM, respectively.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
無料サンプル 1 mg | |||||
1 mg | 在庫あり | ¥ 22,500 | |||
5 mg | 在庫あり | ¥ 50,000 | |||
10 mg | 在庫あり | ¥ 80,000 | |||
25 mg | 在庫あり | ¥ 132,500 | |||
50 mg | 在庫あり | ¥ 189,500 | |||
100 mg | 在庫あり | ¥ 259,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 55,000 |
説明 | GSK2256294A (GSK 2256294) is potent, selective inhibitor of recombinant human, rat and mouse sEH with IC50 of 27 pM, 61 pM and 189 pM, respectively. |
ターゲット&IC50 | sEH:189 pM (mouse), sEH:27 pM (human), sEH:61 pM (rat) |
別名 | GSK 2256294 |
分子量 | 447.46 |
分子式 | C21H24F3N7O |
CAS No. | 1142090-23-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 45 mg/mL (100.57 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GSK2256294A 1142090-23-0 Metabolism Others Epoxide Hydrolase GSK-2256294A Inhibitor GSK 2256294 inhibit cigarette smoke-exposure model GSK2256294 oral COPD cardiovascular inflammation GSK-2256294 inhibitor